Abstract
Background & Aims: Brazil is undergoing a rapid epidemiologic transition in inflammatory bowel disease (IBD). We aimed to characterize the temporal evolution of IBD in Brazil from 2012 to 2025 and forecast its burden through 2035, positioning the country within a global four-stage model.Methods: This nationwide, population-based study utilized the DATASUS database via the TT Disease Explorer platform. We identified individuals with Crohn’s Disease (CD), Ulcerative Colitis (UC), and IBD-Unclassifiable (IBD-U) using validated ICD-10 codes from the public healthcare system. Temporal trends (Annual Average Percent Changes: AAPCs) and autoregressive integrated moving average (ARIMA) modeling was used to forecast incidence and prevalence.Results: A total of 337,539 IBD patients were identified. Between 2012 and 2025, IBD prevalence rose from 29·85 to 158·18 per 100,000 inhabitants and IBD incidence rose from 9·35 to 12·34 per 100,000 inhabitants. The UC:CD prevalence ratio increased from 1·53:1 to 2·1:1. Hotspots were concentrated in the South and Southeast regions. ARIMA models forecast that IBD prevalence will reach 264·4 per 100,000, while incidence is forecasted to rise to 22·72 per 100,000 by 2035.Conclusions: The incidence and prevalence in Brazil are rising significantly. By 2035, this escalating burden will necessitate a structural shift in the public healthcare systems toward longitudinal models of chronic care management.